Boston Family Office LLC Novo Nordisk A S Transaction History

Boston Family Office LLC

  • $1.48 Billion
  • Q3 2024

A detailed history of Boston Family Office LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Boston Family Office LLC holds 44,524 shares of NVO stock, worth $3.89 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
44,524
Previous 43,244 2.96%
Holding current value
$3.89 Million
Previous $6.17 Million 14.13%
% of portfolio
0.36%
Previous 0.44%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$119.07 - $145.42 $152,409 - $186,137
1,280 Added 2.96%
44,524 $5.3 Million
Q2 2024

Aug 12, 2024
SELL
$122.71 - $146.91 $338,679 - $405,471
-2,760 Reduced 6.0%
43,244 $6.17 Million
Q1 2024

May 13, 2024
SELL
$102.11 - $135.92 $310,005 - $412,653
-3,036 Reduced 6.19%
46,004 $5.91 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $2.23 Million - $4.89 Million
24,520 Added 100.0%
49,040 $4.46 Million
Q1 2023

May 10, 2023
SELL
$132.34 - $159.14 $551,593 - $663,295
-4,168 Reduced 14.53%
24,520 $3.9 Million
Q3 2022

Nov 08, 2022
SELL
$95.28 - $116.93 $394,554 - $484,207
-4,141 Reduced 12.61%
28,688 $2.86 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $51,620 - $60,905
-500 Reduced 1.5%
32,829 $3.66 Million
Q1 2022

May 11, 2022
SELL
$93.1 - $112.54 $334,508 - $404,356
-3,593 Reduced 9.73%
33,329 $3.7 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $101,249 - $123,636
-1,056 Reduced 2.78%
36,922 $4.14 Million
Q3 2021

Nov 15, 2021
SELL
$84.42 - $106.62 $41,956 - $52,990
-497 Reduced 1.29%
37,978 $3.65 Million
Q3 2020

Nov 10, 2020
SELL
$63.69 - $70.22 $518,054 - $571,169
-8,134 Reduced 17.45%
38,475 $2.67 Million
Q2 2020

Aug 06, 2020
SELL
$58.54 - $67.94 $117 - $135
-2 Reduced -0.0%
46,609 $3.05 Million
Q1 2020

May 11, 2020
SELL
$49.46 - $64.78 $17,607 - $23,061
-356 Reduced 0.76%
46,611 $2.81 Million
Q1 2019

May 09, 2019
SELL
$46.36 - $52.63 $18,636 - $21,157
-402 Reduced 0.85%
46,967 $2.46 Million
Q4 2018

Feb 12, 2019
SELL
$41.54 - $47.25 $18,277 - $20,790
-440 Reduced 0.92%
47,369 $2.18 Million
Q4 2017

Feb 06, 2018
SELL
$47.53 - $53.73 $144,776 - $163,661
-3,046 Reduced 5.99%
47,809 $2.57 Million
Q3 2017

Nov 13, 2017
BUY
$41.15 - $49.22 $2.09 Million - $2.5 Million
50,855
50,855 $2.45 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email